CARDIOLOGY UPDATE 2015
-
City
Davos, Switzerland
Type of event
on site
Invitation
Dear Colleagues
We are pleased to announce the 21st Cardiology Update Course, taking place in Davos, Switzerland from 8-12 February 2015. This four-day programme will offer a comprehensive update of major topics in cardiology, presented by a distinguished international teaching faculty. The course is a joint educational programme of the Zurich Heart House/Foundation for Cardiovascular Research, the University Hospital Zurich, and the European Society of Cardiology (ESC).
The educational objectives are to review and disseminate recent advances in the prevention, diagnosis, and treatment of cardiovascular disease, as well as to discuss their impact on clinical practice. Completing this course will enable attendees to treat patients in accordance with current clinical evidence over the broad spectrum of cardiovascular disease.
Cardiology Update is designed for clinicians specialised in cardiology, internal and general medicine. Aside from traditional state-of-the-art lectures, a strong emphasis is placed on interactive education, aiming to provide guidance in everyday practice. The spirit of the course is a stimulating working and learning environment, offering great opportunities for networking among faculty members and participants.
We are looking forward to welcoming you at the next Cardiology Update meeting in 2015.
Thomas F. Lüscher, M.D.
Professor and Chairman Cardiology
University Hospital Zurich
Switzerland
Bertram Pitt, M.D.
Professor of Medicine Emeritus
University of Michigan School of Medicine
Ann Arbor MI, USA
Thierry C. Gillebert, M.D.
Professor of Cardiology
ESC Education Committee
University of Ghent
Belgium
Ruth Amstein, Ph.D.
Director Zurich Heart House
Foundation for Cardiovascular Research
Switzerland
Programme
Monday, 9/2/15 | Tuesday, 10/2/15 | Wednesday, 11/2/15 | Thursday, 12/2/15
Abstract Booklet of the Poster Sessions
Download the Booklet
Webcasts
All main Lectures in Room Davos 2 can be watched online: www.zhh.ch/elearning
Monday, February 9, 2015
| 08:00-08:15 Room Davos 2 |
Opening and Welcome Address | T.F. Lüscher, Zurich |
| Opening Address by the President of the ESC | F. Pinto, Lisbon | |
| 08:15-09:00 | Paul Lichtlen Lecture Social value and meaningful outcomes in clinical trials research |
S. Pocock, London |
| 09:00-10:00 Room Davos 2 |
Morning Session 1: Atherosclerosis, Genetics Chair: C. Matter, Zurich and B. Pitt, Ann Arbor |
|
| 09:00 | Therapeutic approaches to modulating inflammation and the immune response in atherosclerosis | P. Libby, Boston |
| 09:20 | Lifetime risk: An appropriate tool for preventive interventions? | J. Deanfield, London |
| 09:40 | Personalised care in the age of the patient genome | G. Pitt, Durham |
| 10:00-10:30 | Coffee | |
| 10:30-11:30 Room Davos 2 |
Morning Session 2: Hypertension Chair: F. Pinto, Lisbon and D. Wood, London |
|
| 10:30 | The new ESC/JCN Guidelines: impact on clinical practice | F. Ruschitzka, Zurich |
| 10:50 | Renal nerve ablation: where to go? | T.F. Lüscher, Zurich |
| 11:10 | Salt, blood pressure and cardiovascular events: Is salt restriction relevant? | S. Yusuf, Hamilton |
| 12:00-13:15 Room Davos 2 |
Satellite Symposium Servier: Contemporary Issues in Hypertension Chair: F. Ruschitzka, Zurich (A lunch bag will be offered) |
|
| 12:00 | Introduction | F. Ruschitzka, Zurich |
| 12:05 | How well are hypertensive patients treated? | F. Mach, Geneva |
| 12:25 | Value of fixed combination treatments in hypertensive patients with comorbidities | J.-J. Mourad, Paris |
| 12:45 | Challenges in hypertension management: Interactive case discussion | I. Sudano, Zurich |
| 13:05 | Discussion and take-home message | F. Ruschitzka, Zurich |
| 13:30-15:00 Room Davos 2 |
Afternoon Session 1: Risk Factors and Prevention Chair: P. Libby, Boston and S. Sharma, London |
|
| 13:30 | EUROASPIRE IV: Prevention at work in Europe | D. Wood, London |
| 13:52 | Risk factors and outcomes for CVD, cancers, kidney and lung diseases globally: the PURE Study | S. Yusuf, Hamilton |
| 14:14 | Environmental hazards – air pollution and noise as novel risk factors | T. Gori, Mainz |
| 14:36 | Testosterone: a novel treatment for prevention of cardiovascular disease? | F. Mach, Geneva |
| 15:00-15:30 | Coffee | |
| 15:30-16:30 | Meet the Expert Sessions (Parallel Sessions) |
|
| Schwarzhorn | Prevention Guidelines in Europe and the US Experts and short presentations: P. Libby, Boston and D. Wood; London |
|
| Seehorn | Hypertension: Case Based Management Experts: T.F. Lüscher, Zurich and S. Yusuf, Hamilton Cases: T. Gori, Mainz and I. Sudano, Zurich |
|
| Wisshorn | Sports Cardiology Experts: D. Corrado, Padova and S. Sharma, London Cases: J. Niebauer, Salzburg and C. Schmied, Zurich |
|
| 15:30-16:30 Foyer |
Poster Session: Atherosclerosis, Risk Factors, Prevention Chair: G. Pitt, Durham |
|
| 16:30-17:30 Room Davos 2 |
Afternoon Session 2A: Sports Cardiology Chair: F. Mach, Geneva and C. Schmied, Zurich |
|
| 16:30 | Current concepts in cardiac screening | J. Niebauer, Salzburg |
| 16:50 | Recommendations for sports participation in athletes with known cardiovascular disease | D. Corrado, Padova |
| 17:10 | “Paracelsus reloaded” – searching for the perfect “dose” of physical activity | S. Sharma, London |
| Room Davos 1 16:30-17:30 | Afternoon Session 2B: Diabetes / Obesity Chair: G. Pitt, Durham and S. Yusuf, Hamilton |
|
| 16:30 | New ESC Guidelines on diabetes, pre-diabetes and cardiovascular disease | F. Cosentino, Stockholm |
| 17:10 | Bariatric surgery in obesity and type 2 diabetes | E. Osto, Zurich |
| 17:30-18:00 | Apéro Riche (for participants of the Satellite Symposia only) |
|
| 18:00-19:15 Room Davos 2 |
Satellite Symposium Bayer Healthcare Atrial Fibrillation, Cardioversion and NOACs: Practical Considerations and Patient Management Chair: T.F. Lüscher, Zurich and F. Pinto, Lisbon |
|
| 18:00 | Introduction | T.F. Lüscher, Zurich |
| 18:10 | NOACs in AF patients undergoing cardioversion: Overview and latest data | A.J. Camm, London |
| 18:30 | Cardioversion and beyond: Guideline recommendation and clinical experience with NOACs | J. Steffel, Zurich |
| 18:55 | Practical aspects and cardiovascular profile of rivaroxaban | B. Meier, Berne |
| 19:10 | Discussion and take-home message | F. Pinto, Lisbon |
| 18:00-19:15 Room Davos 1 |
Satellite Symposium Amgen: Let’s Meet PCSK-9 Inhibition – Let’s Meet LDL Targets Chair: J. Chapman, Paris |
|
| 18:00 | Introduction by the chairman | |
| 18:05 | I AM the high risk patient – current treatment and current outcomes | J. Chapman, Paris |
| 18:25 | The lower is “The Better”! Do YOU guidelines agree? | A. Catapano, Milan |
| 18:45 | Familial hyperlipidemia: the catapult to high risk | J. Deanfield, London |
| 19:05 | Discussion | all |
| 19:20-20:15 Room Schwarzhorn |
Clinical Decision Seminar Pearls of Echocardiography / Advanced Echo Imaging Panel and Cases: F.C. Tanner, Zurich and M. Zuber, Othmarsingen and Zurich |
|
| 19:20-20:15 Room Seehorn |
Clinical Decision Seminar Cardiovascular Imaging: CMR, CT and Nuclear Chair: J.J. Bax, Leiden and F. Faletra, Lugano Cases: O. Gämperli, Zurich and R. Manka, Zurich |
|
Tuesday, February 10, 2015
| 08:00-09:30 Room Davos 2 |
Morning Session 1: Lipid Management Chair: J. Deanfield, London and T.F. Lüscher, Zurich |
|
| 08:00 | US (AHA/ACC) versus ESC Guidelines: Who should get a statin? | F. Mach, Geneva |
| 08:22 | HDL-Cholesterol – an enigma? | U. Landmesser, Berlin |
| 08:44 | LDL-C lowering in CVD prevention | U. Laufs, Homburg/Saar |
| 09:06 | PCSK-9 inhibitors – super statins on the horizon? | P. Libby, Boston |
| 09:30-10:00 | Coffee | |
| 10:00-11:30 Room Davos 2 |
Morning Session 2A: Stable Coronary Artery Disease Chair: F. Crea, Rome and F. Pinto, Lisbon |
|
| 10:00 | Coronary microvascular dysfunction | P. Camici, Milan |
| 10:22 | Heart rate reduction in angina and heart failure: a paradox? | K. Swedberg, Gothenburg |
| 10:44 | Stress as a cause of cardiac disease | T.F. Lüscher, Zurich |
| 11:06 | The patient presenting with stable angina: drugs or devices? | B. Gersh, Rochester |
| 10:00-11:30 Room Davos 1 |
Morning Session 2B: Cardiac Imaging Chair: F. Faletra, Lugano and F.C. Tanner, Zurich |
|
| 10:00 | Differential imaging: How to select the right tool for the patient’s problem? | J.J. Bax, Leiden |
| 10:22 | Myocardial strain imaging: How useful is it in decision making? | O. Smiseth, Oslo |
| 10:44 | Hybrid imaging | O. Gämperli, Zurich |
| 11:06 | Cardiac MRI in coronary artery disease and heart failure | R. Manka, Zurich |
| 12:00-13:15 Room Schwarzhorn |
Satellite Symposium Sanofi Novel Therapeutic Approach for the Management of Dyslipidemia Chair: U. Landmesser, Berlin and F. Mach, Geneva (A lunch bag will be offered) |
|
| 12:00 | Introduction | U. Landmesser, Berlin |
| 12:10 | Management of hypercholesterolemia: Where do the challenges lie? | J. Deanfield, London |
| 12:30 | PCSK-9 inhibition: mechanism of action | S. Krähenbühl, Basel |
| 12:50 | Clinical development of alirocumab: a fascinating journey | T.F. Lüscher, Zurich |
| 13:10 | Discussion and take-home message | F. Mach, Geneva |
| 12:00-13:15 Room Seehorn |
Satellite Symposium Daiichi Sankyo Mass-Tailored Treatment of Hypertension for the Young and the Old Chair: B. Meier, Berne (A lunch bag will be offered) |
|
| 12:00 | Introduction | B. Meier, Berne |
| 12:10 | News for elderly patients with hypertension | M. Burnier, Lausanne |
| 12:30 | Individualised blood pressure goals in diabetes in analogy to HbA1C goals? | R. Lehmann, Zurich |
| 12:50 | Hypertension and athlete’s heart | C. Schmied, Zurich |
| 13:10 | Discussion and take-home message | B. Meier, Berne |
| 13:30-18:00 Room Studio |
Echo Hands-on Sessions Interactive hands-on tutorials. One tutorial has a duration of 60 minutes and is limited to four participants. Extra cost: CHF 80. Previous registration necessary. |
|
| 13:30-15:00 Room Davos 2 |
Afternoon Session 1: Thrombosis and Pulmonary Embolism Chair: A.J. Camm, London and J. Steffel, Zurich |
|
| 13:30 | Diagnosis of thrombosis and pulmonary embolism | H. Bounameaux, Geneva |
| 13:52 | ESC Guidelines on pulmonary embolism: recommendations and patient management | A. Torbicki, Warszawa |
| 14:14 | Comparison of the efficacy and safety of NOACs | R.P. Giugliano, Boston |
| 14:36 | Ultrasound-assisted thrombolysis for acute pulmonary embolism | N. Kucher, Berne |
| 15:00-15:30 | Coffee | |
| 15:30-16:30 | Meet the Expert Sessions (Parallel Sessions) |
|
| Schwarzhorn | Thrombosis and Pulmonary Embolism: Implementing the New Guidelines Expert: A.J. Camm, London Cases: N. Kucher, Berne and A. Torbicki, Warszawa |
|
| Seehorn | Ablation of Ventricular Tachycardias: When and How? Expert: F. Duru, Zurich Cases: S. Benussi, Zurich and L. Haegeli, Zurich |
|
| Wisshorn | Pulmonary Hypertension Experts: R. Naeije, Brussels and J.-L. Vachiery, Brussels Cases: E. Grünig, Heidelberg and S. Ulrich, Zurich |
|
| 15:30-16:30 Foyer |
Poster Session: Arrhythmias, Acute Coronary Syndromes Revascularisation, Heart Failure Chair: T. Gillebert, Ghent |
|
| 16:30-17:30 Room Davos 2 |
Afternoon Session 2A: Ventricular Arrhythmias Chair: B. Gersh, Rochester and O. Smiseth, Oslo |
|
| 16:30 | Ventricular extrasystoles: always harmless? | G. Hindricks, Leipzig |
| 16:50 | Ventricular tachycardia: drugs versus devices | A.J. Camm, London |
| 17:10 | Role of catheter ablation for the management of VT | H. Calkins, Baltimore |
| 16:30-17:30 | Afternoon Session 2B: Pulmonary Hypertension Chair: N. Kucher, Berne and S. Ulrich, Zurich |
|
| 16:30 | Pathophysiology of PH – the right heart matters | R. Naeije, Brussels |
| 16:50 | PH under pressure – the value of stress echo and rehabilitation | E. Grünig, Heidelberg |
| 17:10 | Therapeutic approaches in PH and the new ESC Guidelines | J.-L. Vachiery, Brussels |
| 17:30-18:00 | Apéro Riche (for participants of the Satellite Symposia only) | |
| 18:00-19:15 Room Davos 2 |
Satellite Symposium AstraZeneca From Acute Care to Long Term Benefit in ACS Chair: T.F. Lüscher, Zurich |
|
| 18:00 | Introduction | T.F. Lüscher, Zurich |
| 18:10 | Improving outcomes in STEMI and optimising duration of dual antiplatelet therapy | S.K. James, Uppsala |
| 18:35 | DAPT – when to start, when to stop? | R.F. Storey, Sheffield |
| 19:00 | Panel discussion | |
| 18:00-19:15 Room Davos 1 |
Satellite Symposium Biotronik Modern Management of Cardiac Device Patients Chair: J. Steffel, Zurich |
|
| 18:00 | Introduction by the chairman | |
| 18:05 | Cardiac resynchronisation therapy in 2015: What, for whom – and for whom not | F. Ruschitzka, Zurich |
| 18:25 | Remote monitoring for device patients – the modern standard | G. Hindricks, Leipzig |
| 18:45 | Rate-adaptive pacing – current concepts and systems | J. Steffel, Zurich |
| 19:05 | Panel discussion | all |
| 19:20-20:15 Room Schwarzhorn |
Symposium Perioperative Management of Cardiac Patients Chair: D. Atar, Oslo |
|
| 19:20 | The new guidelines: a bumpy way | T.F. Lüscher, Zurich |
| 19:35 | Medical management of cardiac patients during non-cardiac surgery | D. Spahn, Zurich |
| 19:55 | Surgery after PCI: How many anticoagulants/antithrombotics, which stent? | R. Binder, Zurich |
| 19:20-20:15 | Clinical Decision Seminar Patients with ICD and CRT: Trouble Shooting Panel and Cases: G. Hindricks, Leipzig and J. Steffel, Zurich |
|
Wednesday, February 11, 2015
| 08:00-09:30 Room Davos 2 |
Morning Session 1: Atrial Fibrillation Chair: C. Brunckhorst, Zurich and A.J. Camm, London |
|
| 08:00 | Critical appraisal of AF management guidelines across the Atlantic | H. Calkins, Baltimore |
| 08:22 | Stroke prevention in AF: drugs or devices? | B. Meier, Berne |
| 08:44 | Curative treatment of AF: too far to reach? | G. Hindricks, Leipzig |
| 09:06 | Risk stratification in the elderly with AF: therapeutic implications | D. Atar, Oslo |
| 09:30-10:00 | Coffee | |
| 10:00-11:30 Room Davos 2 |
Morning Session 2: Cardiomyopathies, Sudden Cardiac Death Chair: F. Duru, Zurich and T. Gillebert, Ghent |
|
| 10:00 | Genetics of cardiomyopathies | P. Elliott, London |
| 10:22 | Management of hypertrophic cardiomyopathy: evidence and uncertainties | B. Gersh, Rochester |
| 10:44 | The new ESC Guidelines on hypertrophic cardiomyopathy | P. Elliott, London |
| 11:06 | Left ventricular non-compaction | F.C. Tanner, Zurich |
| 12:00-13:15 Room Davos 2 |
Satellite Symposium Daiichi Sankyo Meeting the Challenges in Atrial Fibrillation Management Chair: B. Meier, Berne (A lunch bag will be offered) |
|
| 12:00 | Introduction | B. Meier, Berne |
| 12:05 | Balancing benefit and risk during anticoagulant therapy for AF | F. Mach, Geneva |
| 12:25 | What does ENGAGE AF-TIMI 48 add to the management of patients with atrial fibrillation | R. Giugliano, Boston |
| 12:45 | Clinical practice of oral anticoagulation – implication of recent clinical trials | J. Steffel, Zurich |
| 13:05 | Panel discussion | all |
| 13:30-15:00 Room Davos 2 |
Afternoon Session 1: Percutaneous Interventions Chair: B. Meier, Berne and T. Mocceti, Lugano |
|
| 13:30 | Bioresorbable scaffolds: the 4th revolution of PCI | S. Windecker, Berne |
| 13:50 | Is FFR essential to guide PCI? | W. Wijns, Aalst |
| New ESC/EACTS Revascularisation Guidelines | ||
| 14:10 | The surgeon’s view | V. Falk, Berlin |
| 14:25 | The interventionalist’s view | S. Windecker, Berne |
| 14:40 | Conclusion: what intervention for which patient? | B. Gersh, Rochester |
| 15:00-15:30 | Coffee | |
| 15:30-16:30 | Meet the Expert Sessions / Live in-a-Box (Parallel Sessions) |
|
| Schwarzhorn | Biomarkers in Risk Stratification Expert: C. Matter, Zurich Cases: R. Klingenberg, Zurich and C. Müller, Basel |
|
| Seehorn | Cardiomyopathies, sudden death Experts: B. Gersh, Rochester and H. Calkins, Baltimore Cases: T. Gillebert, Gent and C. Gruner, Zurich |
|
| Flüela | What is a Significant Coronary Stenosis? Coronary Flow and Pressure Measurement as a Guide Expert: W. Wijns, Aalst Cases: O. Gämperli, Zurich and K. Weber, Winterthur |
|
| Wisshorn | Live in-a-Box: TAVI Implantation Indications: A. Vahanian, Paris How to perform TAVI: F. Nietlispach, Zurich |
|
| 15:30-16:30 | Poster Session: Acute Coronary Syndromes, Revascularisation, Heart Failure Moderator: F. Crea, Rome |
|
| 16:30-17:30 Room Davos 2 |
Afternoon Session 2A: Mitral Valve Regurgitation Chair: V. Falk, Berlin and S. Windecker, Berne |
|
| 16:30 | The role of imaging in catheter-based procedures | J.J. Bax, Leiden |
| 16:50 | How to treat mitral regurgitation: Surgery vs. percutaneous / repair vs. replacement | F. Maisano, Zurich |
| 17:10 | Current and new percutaneous devices on the horizon | A. Vahanian, Paris |
| 16:30-17:30 Room Davos 1 |
Afternoon Session 2B: Acute Coronary Syndromes Chair: O. Gämperli, Zurich and B. Gersh, Rochester |
|
| 16:30 | Early diagnosis of acute MI: novel strategies | C. Müller, Basel |
| 16:50 | Mechanisms of ACS: the clinical perspective | F. Crea, Rome |
| 17:10 | Biomarkers in risk stratification of patients with ACS: The Swiss SPUM registry | C. Matter, Zurich |
| 17:30-18:00 | Apéro Riche (for participants of the Satellite Symposia only) | |
| 18:00-19:15 Room Davos 2 |
Satellite Symposium Daiichi Sankyo / Lilly Five Years Prasugrel: What Have we Learned and Where Are we Going? Chair: S. Windecker, Berne |
|
| 18:00 | Revascularisation guidelines 2014 – what has changed how will it impact clinical practice? | S. Windecker, Berne |
| 18:20 | Update on prasugrel – optimising therapy after ACS/PCI | C. Kaiser, Basel |
| 18:40 | Safety profile of clopidogrel and prasugrel in the prospective Swiss ACS/PCI cohort | C. Matter, Zurich |
| 19:00 | Panel discussion | all |
| 19:10 | Take-home message | C. Windecker |
| 19:20-20:15 Room Schwarzhorn |
Clinical Decision Seminar Difficult ECG Interpretations Panel and cases: C. Brunckhorst, Zurich and F. Duru, Zurich and L. Haegeli, Zurich |
|
| 19:20-20:15 Room Seehorn |
Clinical Decision Seminar Tricky Cases in Congenital Heart Disease Chair: J. Deanfield, London Cases: M. Greutmann, Zurich and D. Tobler, Basel |
|
Thursday, February 12, 2015
| 08:00-09:30 Room Davos 2 |
Morning Session 1: Aortic Valve Disease Chair: W. Maier, Zurich and F. Maisano, Zurich |
|
| 08:00 | Imaging for patient selection | J.J. Bax, Leiden |
| 08:22 | TAVI: current state of the art | A. Vahanian, Paris |
| 08:44 | Stroke prevention in TAVI | F. Nietlispach, Zurich |
| 09:06 | TAVI in low and intermediate risk patients | S. Windecker, Berne |
| 09:30-10:00 | Coffee | |
| 10:00-11:30 Room Davos 2 |
Morning Session 2: Heart Failure I Chair: D. Milicic, Zagreb and K. Swedberg, Gothenburg |
|
| 10:00 | Decades of inhibiting the renin angiotensin system | M.A. Pfeffer, Boston |
| 10:22 | Mineral corticoid receptor antagonists | B. Pitt, Ann Arbor |
| 10:44 | Beyond ejection fraction: towards a better assessment of cardiac structure and function in HF | S. Solomon, Boston |
| 11:06 | Comorbidities in heart failure: what a clinician should know | S. Anker, Berlin |
| 12:00-13:15 Room Davos 2 |
Satellite Symposium Novartis Novel Therapies for Chronic Heart Failure – an Expert Panel Discussion Chair: F. Ruschitzka, Zurich (A lunch bag will be offered) |
|
| 12:00 | Introduction | F. Ruschitzka, Zurich |
| 12:05 | Novel therapies for chronic heart failure | K. Swedberg, Gothenburg |
| 12:30 | Expert Panel Discussion Moderation F. Ruschitzka, Zurich Experts K. Swedberg, Gothenburg S. Solomon, Boston T. Suter, Berne | |
| 13:00 | Questions from the audience | |
| 13:30-15:00 Room Davos 2 |
Afternoon Session 1: Heart Failure II Chair: G. Filippatos, Athens and S. Solomon, Boston |
|
| 13:30 | Sleep apnoea and heart failure | P. Ponikowski, Wroclaw |
| 13:52 | The interface of cardiovascular and renal disease | M.A. Pfeffer, Boston |
| 14:14 | When drugs alone are not enough: Cardiac resynchronization therapy | J. Steffel, Zurich |
| 14:36 | Telemonitoring in heart failure: IN-TIME and beyond | G. Hindricks, Leipzig |
| 15:00-15:15 | Coffee | |
| 15:15-16:00 | Meet the Expert Sessions (Parallel Sessions) |
|
| Schwarzhorn | How to Treat Patients with HFrEF Expert: K. Swedberg, Gothenburg Cases: F. Enseleit, Zurich and M. Frank, Zurich |
|
| Seehorn | Diagnosing and Treating HFpEF Expert: P. Ponikowski, Wroclaw Cases: A. Flammer, Zurich and S. Solomon, Boston |
|
| Wisshorn | Devices in Heart Failure Expert: G. Hindricks, Leipzig Cases: E. Holy, Zurich and J. Steffel, Zurich |
|
| 16:00-17:00 Room Davos 2 |
Afternoon Session 2: Acute and Advanced Heart Failure Chair: B. Pitt, Ann Arbor and P. Ponikowski, Wroclaw |
|
| 16:00 | Early management of acute HF: Time is also muscle | G. Filippatos, Athens |
| 16:20 | Novel strategies in the management of acute HF | F. Ruschitzka, Zurich |
| 16:40 | Implantable left ventricular assist devices: rise of the machines | D. Milicic, Zagreb |
| 17:00-17:15 | Poster Award | G. Pitt, Durham B. Pitt, Ann Arbor |
| 17:15-17:45 | Davos Lecture Ventricular remodelling: a personal journey | M.A. Pfeffer, Boston |
| 17:45-18:00 | Closing Remarks | B. Pitt, Ann Arbor, T.F. Lüscher, Zurich |
Speakers
Committees of Cardiology Update
Advisory Board and Programme Committee
Ruth Amstein, Zurich, CH
Jeroen J. Bax, Leiden, NL
Paolo G. Camici, Milan, IT
Filippo Crea, Rome, IT
Volkmar Falk, Berlin, DE
Thierry C. Gillebert, Ghent, BE
Peter Libby, Boston, MA, USA
Thomas F. Lüscher, Zurich, CH
Bernhard Meier, Berne, CH
Marc A. Pfeffer, Boston, MA, USA
Fausto Pinto, Lisbon, PT
Bertram Pitt, Ann Arbor, MI, USA
Otto A. Smiseth, Oslo, NO
Karl B. Swedberg, Gothenburg, SE
Alec Vahanian, Paris, FR
Panos Vardas, Heraklion, GR
William Wijns, Aalst, BE
Stephan Windecker, Berne, CH
Salim Yusuf, Hamilton, ON, CA
In collaboration with BWH
Local Programme Committee Zurich
Ronald Binder
Corinna Brunckhorst
Firat Duru
Frank Enseleit
Andreas Flammer
Michelle Frank
Oliver Gämperli
Matthias Greutmann
Christiane Gruner
Laurent Haegeli
Roland Klingenberg
Willibald Maier
Francesco Maisano
Robert Manka
Christian Matter
Fabian Nietlispach
Frank Ruschitzka
Christian M. Schmied
Jan Steffel
Isabella Sudano
Felix C. Tanner
Silvia Ulrich Somaini
Teaching Faculty
International Faculty
Anker Stefan, Berlin, DE
Atar Dan, Oslo, NO
Bax Jeroen J., Leiden, NL
Bounameaux Henri, Geneva, CH
Burnier Michel, Lausanne, CH
Calkins Hugh, Baltimore, US
Camici Paolo G., Milan, IT
Camm John A., London, GB
Catapano Alberico L., Milan, IT
Chapman John, Paris, FR
Corrado Domenico, Padova, IT
Cosentino Francesco, Stockholm, SE
Crea Filippo, Rome, IT
Deanfield John E., London, GB
Elliott Perry, London, GB
Faletra Francesco, Lugano, CH
Falk Volkmar, Berlin, DE
Filippatos Gerasimos, Athens, GR
Gersh Bernard, Rochester, US
Gillebert Thierry C., Ghent, BE
Giugliano R.P., Boston , US
Gori Tommaso, Mainz, DE
Grünig Ekkehard, Heidelberg, DE
Hindricks Gerhard, Leipzig, DE
James Stefan K., Uppsala, SE
Kaiser Christoph, Basel, CH
Krähenbühl Stephan, Basel, CH
Kucher Nils, Berne, CH
Landmesser Ulf, Berlin, DE
Laufs Ulrich, Homburg, DE
Libby Peter, Boston, US
Lüscher Thomas F., Zurich, CH
Mach François, Geneva, CH
Maisano Francesco, Zurich, CH
Meier Bernhard, Berne, CH
Milicic Davor, Zagreb, HR
Mocetti Tiziano, Lugano, CH
Mourad Jean-Jacques, Paris, FR
Müller Christian, Basel, CH
Naeije Robert, Brussels, BE
Niebauer Josef, Salzburg, AT
Pfeffer Marc A., Boston, US
Pinto Fausto José, Lisbon, PT
Pitt Bertram, Ann Arbor, US
Pitt Geoffrey S., Durham, US
Pocock Stuart, London, UK
Ponikowski Piotr, Wroclaw, PL
Ruschitzka Frank, Zurich, CH
Sharma Sanjay, London, GB
Smiseth Otto A., Oslo, NO
Solomon Scott David, Boston, US
Spahn Donat, Zurich , CH
Storey Robert F., Sheffield, UK
Suter Thomas, Berne, CH
Swedberg Karl B., Gothenborg, SE
Tobler Daniel, Basel, CH
Torbicki Adam, Warsaw, PL
Vachiery Jean-Luc, Brussels, BE
Vahanian Alec, Paris, FR
Weber Klaus, Winterthur, CH
Wijns William, Aalst ,BE
Windecker Stephan, Berne, CH
Wood David, London, GB
Yusuf Salim, Hamilton, CA
Local Zurich Faculty
Benussi Stefano
Binder Ronald
Brunckhorst Corinna
Duru Firat
Enseleit Frank
Flammer Andreas
Frank Michelle
Gämperli Oliver
Greutmann Matthias
Gruner Christiane
Haegeli Laurent
Holy Erik Walter
Klingenberg Roland
Lehmann Roger
Maier Willibald
Manka Robert
Matter Christian
Nietlispach Fabian
Osto Elena
Schmied Christian M.
Steffel Jan
Sudano Isabella
Tanner Felix C.
Ulrich Somaini Silvia
Zuber Michel
Last update: January 2015
Information
Venue
Congress Center, Davos, Switzerland (www.davoscongress.ch)
Registration
Registrations can be made exclusively online: Online Registration
Registration fee before 20 December 2014, CHF (Swiss Francs) 980.00
Registration fee after 20 December 2014, CHF 1100.00
On-site Registration: CHF 1200.00
Registration fee for fellows and nurses (identification requested): CHF 490.00
Single day tickets Monday – Thursday: CHF 300.00
Registration will be confirmed upon receipt of payment.
Echo Hands-on Session: CHF 80.00 (limited to 32 participants)
Group Registration
For group registration a minimum of 10 participants is required. Please contact Mrs. Esther Willi (esther.willi@usz.ch) to obtain further information. Congress documents and bags can be collected as early pick-up upon request.
Modification & Cancellation
All modifications or cancellations must be notified in writing (by mail, fax or e-mail) to Davos Congress. For each modification requested by the participant, CHF 50.00 will be charged for administrative costs. In case of cancellation up to 14 January 2015, deposits will be refunded less 35% for administrative costs. After this date, no refund will be possible.
Methods of payment
The fees should be paid in Swiss Francs (CHF) and settled by the following credit cards: VISA or Eurocard/Mastercard.
Contact: Davos Congress, Mrs. Sandra Sutter (cardio@davos.ch).
Hotel Reservation
Hotel rooms are available at a special convention rate. Reservations can be made at Davos Congress, Mrs. Sandra Sutter (cardio@davos.ch).
Abstracts
Abstracts for the Poster Session can be submitted exclusively on our website (→ Abstract Submission). An Abstract Booklet will be published.
Deadline for submission: expired.
Registration Desk
The registration desk and congress secretariat is located in the foyer of the Congress Center.
Opening hours:
Sunday, 8 February 2015: 16:00–18:30
Monday-Wednesday, 9-11 February 2015: 07:30–12:00 and 14:00–19:00
Thursday, February 12, 2015: 08:00–12:00 and 14:00–18:00
Accreditation
Cardiology Update is recognised by the following medical societies and associations as accredited
continuing education:
EBAC, European Board for Accreditation in Cardiology (24 CME credits)
EACCME, European Accreditation Council for Continuing Medical Education (24 CME credits)
Swiss Society of Cardiology (30 CME credits category 1A)
Swiss Society of Internal Medicine (30 CME credits category 1A)
German Cardiac Society (30 CME credits)